PaSmax
"PaSmax" is a figurative mark owned by Biosynth GmbH, filed at the EUIPO on January 11, 2016. It is registered and covers classes 1, 5 and 42.
- Status
- Registered
- Since April 27, 2016
- Filed
- January 11, 2016
- Registered
- April 25, 2016
- Expires
- January 11, 2026
- Application no.
- 014988901
- Registration no.
- 014988901
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Figurative mark
- 3 classes
Who owns PaSmax
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Biosynth GmbH
Representative
Dentons Europe (Germany) GmbH & Co. KG
Dentons Europe (Germany) GmbH & Co. KG
What the mark covers
The products and services PaSmax is filed for, grouped by Nice class.
Chemical substances, chemical materials and chemical preparations, and natural elements; Chemical compositions and materials for use in science; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Chemicals for use in coating surgical instruments [other than pharmaceuticals]; Chemicals for use in coating medical instruments [other than pharmaceuticals]; Chemicals for use in coating veterinary instruments [other than pharmaceuticals]; Chemicals for use in immuno-assay testing [other than medical or veterinary]; Chemicals for use in molecular separation processes [other than medical and veterinary]; Chemical preparations for use in the manufacture of pharmaceuticals; Chemicals for use in industry and science; Chemical products for biotechnological purposes [industrial]; Chemical preparations for use in the manufacture of biocides; Chemicals for use in the pharmaceutical industry; Chemicals for use in biotechnological product development; Chemical reagents, other than for medical or veterinary purposes; Chemical reagents for use in diagnostic tests, other than for medical or veterinary use; Chemical reagents for laboratory use, other than for medical or veterinary use; Chemical reagents for use in analytical tests, other than for medical or veterinary use; Chemical reagents for use in biotechnology, other than for medical or veterinary use; Chemical reagents for use in industry; Chemical reagents for molecular biology, other than for medical or veterinary use; Chemical substances for use in manufacture; Chemical substances for use in the biochemical industry; Chemical substances for use in the biotechnological industry; Chemical substances for use in the production of drugs; Reagents for use in diagnostic tests [other than for medical or veterinary purposes]; Reagents for use in the development of monoclonal antibodies [other than for medical or veterinary purposes]; Reagents for industrial purposes; Reagents for scientific or medical research use; Reagents for research purposes; Diagnostic scanning agents for in-vivo use [other than medical]
Medical and veterinary preparations and articles; Pharmaceuticals and natural remedies; Diagnostic preparations; Drug delivery agents that facilitate the delivery of pharmaceutical preparations; Medicines for veterinary purposes; Chemical preparations for medical purposes; Chemical preparations for veterinary purposes; Biochemical preparations for medical use; Biochemical preparations for veterinary use; Pharmaceutical preparations for animals; Pharmaceutical preparations for veterinary use; Antibacterial pharmaceuticals; Anti-diabetic pharmaceuticals; Antineoplastics; Anti-viral agents; Medicine; Medicines for human purposes; Biopharmaceuticals for the treatment of cancer; Biological preparations for the treatment of cancer; Biotechnological preparations for medical use; Chemico-pharmaceutical preparations; Chemicals for pharmaceutical use; Chemical preparations for pharmaceutical purposes; Chemotherapeutics; Immunotherapeutic agents for bacterial infections; Medicinal preparations and substances; Antitumor drugs; Cardiovascular pharmaceuticals; Ocular pharmaceuticals; Pharmaceutical drugs; Pharmaceutical creams; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of disorders caused by bacteria; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for use in hematology; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the treatment of diseases of the endocrine system; Pharmaceutical preparations for the treatment of diseases of the metabolic system; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for human use; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of cardiovascular disease; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations; Tumor suppressing agents; Anti-leprotic agents; Drug delivery agents; Cytostatics for medical purposes; Cytostatics for pharmaceutical purposes
Science and technology services; Natural science services; Medical and pharmacological research services; Consultancy relating to research and development in the field of therapeutics; Consultancy pertaining to pharmacology; Consultancy in the field of pharmaceutical research; Consultancy relating to laboratory testing; Development of pharmaceutical preparations and medicines; Research and development of vaccines and medicines; Research on the subject of pharmaceuticals; Research and development for the pharmaceutical industry; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Scientific research in the field of pharmacy; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific investigations for medical purposes; Advisory services relating to chemical reagents; Advisory services relating to biochemistry; Biochemistry services; Biochemistry research services; Biomedical research services; Research relating to biotechnology; Chemical research and analysis services; Chemistry consultation; Chemical laboratories; Services of a chemical and/or biological laboratory; Chemical analysis; Research and development in the pharmaceutical and biotechnology fields; Biochemical research and development; Research and development services in the field of antibody technology; Research and development services in the field of chemistry; Laboratory research in the field of chemistry; Scientific analysis
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2026/104 Section C.2.1
- Bulletin 2023/223 Section C.1.3
- Bulletin 2023/221 Section C.2.2
- Bulletin 2016/078 Section B.1
- Bulletin 2016/009 Section A.1
About PaSmax
Who owns the trademark "PaSmax"?
The EUIPO trademark "PaSmax" (application 014988901) is owned by Biosynth GmbH.
What is the status of "PaSmax"?
Its status at the EUIPO is: registered.
When was "PaSmax" registered?
It was registered on April 25, 2016 and is due to expire on January 11, 2026.
Get this data via the API
Everything on this page comes from the Signa API. Pull PaSmax and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d470c-199a-7335-90ea-a67dac315572
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d470c-199a-7335-90ea-a67dac315572",
"object": "trademark",
"mark_text": "PaSmax",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "014988901",
"filing_date": "2016-01-11",
"nice_classes": [
1,
5,
42
],
"owners": [
{
"name": "Biosynth GmbH",
"entity_id": "ent_019ebbec-3419-71dc-812e-b18e646beae4"
}
]
}